Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

CEFTRIAXONE INJECTI

Awarded
SPE2DP26F8782Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Defense Logistics Agency award SPE2DP26F8782, issued on August 5, 2026, is a firm-fixed-price delivery order under contract SPE2DX25D9900. The contract was awarded to DMS Pharmaceutical Group Inc (CAGE 1UNB0) for the procurement of one package of Ceftriaxone Injecti (NSN 6505015544282) for a total price of $45.19. The product must be manufactured under CAGE codes 32655, 4RP13, or 6XJQ8 and is associated with NDC 00143-9857-25. The delivery is scheduled for August 20, 2026, to Building 1509 West 6th Street, Fort Stewart, GA 31314-5185. Shipping must be conducted via the fastest traceable means, specifically prohibiting the use of parcel post. The contract is established as FOB Destination, with the contractor bearing all costs and risks until delivery. Inspection and acceptance will occur at the destination. Administrative tracking for the shipment includes Transport Control Number W33RBS62030573 and Required Delivery Date 555.

General Info

DLA awarded DMS Pharmaceutical Group $45.19 for Ceftriaxone Injecti delivery by August 20.

Contract Value

$45.19

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

2

SPE2DP-26-F-8782 - Ceftriaxone Injecti

PDF, High priority: read this firstaward
High

SPE2DP26F8782.pdf

PDF, Low priorityother
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F8782 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $45.19 Award Date: 08-05-2026 Delivery order under: SPE2DX25D9900 Line items: - CEFTRIAXONE INJECTI (NSN/Part 6505015544282, PR 7017770658)

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
Solicitation # 36E79727R0039
The Department of Veterans Affairs Enterprise Procurement Office intends to issue Request for Proposal 36E79727R0039 for an unrestricted procurement of Latanoprost Ophthalmic Solution. This contract will establish an uninterrupted source of supply for the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. Distribution will be managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The award will be granted to a single responsible offeror for a base period of one year with four pre-priced one-year option periods. The solicitation is expected to be issued in commercial item format per FAR Part 12 on approximately October 21, 2026, with a tentative closing date of November 4, 2026, under NAICS code 325412. Strict labeling and packaging requirements apply to this procurement. Offerors must provide the exact drug name as it appears on the label and a unique NDC number. The contractor's label must be the sole label on the product, and affixing labels over existing ones is prohibited; however, the label must allow VA labels to adhere securely on top. Additionally, vendors must comply with the American Academy of Ophthalmology’s recommended uniform color-coding system for the caps and labels of all topical ocular medications. This acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. All communications and submissions are to be handled electronically via SAM.gov, with James Sullivan serving as the primary point of contact.
Nac Pharmaceuticals (36E797)

POSTED

about 9 hours ago

DEADLINE

in 18 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS